Furthermore, with regards to TCA cycle regulation, Tsui et al. [36] illustrated that the induction of p53 levels in prostate cancer cells through camptothecin treatment or by an expression vector markedly reduced mitochondrial aconitase expression. Here, TP53 is linked to prostate cancer.